Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,430 Cr₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹4,430 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,430 Cr
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,430 Cr
10.77
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,182.6 Cr -1.4% 0.1% -35.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.4%

0.1%

-35.5%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses